Results 1 to 10 of about 5,588,761 (314)

Hormonal therapy in uterine sarcomas

open access: yesCancer Medicine, 2019
Uterine sarcomas (USs) are a group of rare but aggressive uterine malignancies, accounting for only 1% of the malignant tumors of female reproductive organs. Due to the high rate of recurrence and metastasis, the prognosis of USs is poor.
Yuqin Zang   +6 more
doaj   +2 more sources

Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. [PDF]

open access: yesDiscov Oncol
Cancer remains a major global health challenge, consistently ranking as the second leading cause of mortality worldwide. Despite significant advancements in research and technology, the need to deepen our understanding of tumor biology and improve ...
Zafar A   +4 more
europepmc   +2 more sources

Hormonal therapies and venous thrombosis: Considerations for prevention and management

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Background Venous thromboses are well‐established complications of hormonal therapy. Thrombosis risk is seen with both hormonal contraceptive agents and with hormone replacement therapy for menopause and gender transition.
Corinne LaVasseur   +5 more
doaj   +2 more sources

Profiling and hormonal therapy for acne in women

open access: yesIndian Journal of Dermatology, 2014
Acne vulgaris is the most common condition treated by physicians worldwide. Though most acne patients remit spontaneously, for the ones that do not or are unresponsive to conventional therapy or have obvious cutaneous signs of hyperandrogenism, hormonal ...
Sangita Ghosh   +3 more
doaj   +2 more sources

Past, present, and future of hormonal therapy in recurrent endometrial cancer

open access: yesInternational Journal of Women's Health, 2014
Matthew J Carlson, Kristina W Thiel, Kimberly K LeslieDepartment of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USAAbstract: Endometrial cancer is a heterogeneous disease.
Carlson MJ, Thiel KW, Leslie KK
doaj   +2 more sources

Estetrol: a new estrogen component in combined oral contraceptives: A review [PDF]

open access: yesГинекология, 2023
Estetrol (E4) is a steroid hormone found in the urine of pregnant women in 1965. E4 is produced only during pregnancy and enters the maternal bloodstream through the placenta.
Aida U. Hamadyanova   +7 more
doaj   +1 more source

Assessment of compliance with hormonal therapy in early breast cancer patients with positive hormone receptor phenotype: A single institution study

open access: yesBreast, 2022
Background: Adherence to long-term adjuvant hormonal therapy in hormonal receptors (HR)-positive breast cancer is really challenging and can affect the survival outcome.
Shereef Ahmed Elsamany   +5 more
doaj   +1 more source

Hormonal Therapy for Prostate Cancer.

open access: yesEndocrine reviews, 2021
Huggins and Hodges demonstrated the therapeutic effect of gonadal testosterone deprivation in the 1940s and therefore firmly established the concept that prostate cancer is a highly androgen-dependent disease.
Kunal Desai   +2 more
semanticscholar   +1 more source

Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?

open access: yesCancers, 2022
Simple Summary The most common therapies for severe and recurrent gynecological cancers are hormone therapy and chemotherapy, and responsiveness to therapy is a key component in prognosis and survivability.
Saikat Mitra   +11 more
semanticscholar   +1 more source

Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data

open access: yesBMC Cancer, 2022
Background This study assesses the use of hormonal therapy to treat high-risk localized prostate cancer (HRLPCa) cases diagnosed between 2005 and 2015. Methods All N0-XM0 with ≥T3a, or PCa cases with poorly differentiated feature (equivalent to Gleason ...
Semaw Ferede Abera   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy